Noticias de AZN_US
Noticias del mercado
Últimas noticias sobre AZN_US — 625 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
At the close on September 4, 2026, AstraZeneca stock finished at 12,006.0 on its home market, down 1
AstraZeneca stock edged lower despite the US FDA granting accelerated approval for the company’s new
FDA grants accelerated approval to AstraZeneca's camizestrant, Etcamah, for mutation-driven metastatic breast cancer; sales could reach $5B, impacting the pharm
AstraZeneca stock is trading slightly higher on the London Stock Exchange on September 4, 2026, whil
AstraZeneca stock is trading modestly higher as investors react to a fresh global license agreement
AstraZeneca stock trades near USD 162 as investors digest fresh EU approval for breast cancer therap
Página 1 de 32